fletikumab

chemical compound

Uses your system voice; voice and rate in settings.

Q19904185Snapshot

≈ 1 min read

Names in other languages

  • Englishfletikumab
  • ItalianoFletikumab

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Fletikumab (NNC0109-0012) (INN ) is a monoclonal antibody designed for the treatment of rheumatoid arthritis that targets IL-20. This drug was being developed by Novo Nordisk A/S until Novo ceased work in inflammation.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1148912893 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.